CAMBRIDGE, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies announced today the appointment of Mark D. Angelino, co-founder and former Chief Operating Officer of Generation Bio, to its Board of Directors. Mark brings significant company building and product development experience to the Arbor Board, given his expertise over the past 20 years working with numerous leading pharmaceutical companies.

Read more here:
Arbor Biotechnologies Names Mark D. Angelino to its Board of Directors

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh